CELL & GENE THERAPY INSIGHTS

New horizons in cellular immunotherapy: next-gen platforms and modalities

Guest Editor:
David Morrow, Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS
David Morrow
Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS
October 2020